Vendor Intelligence Report: Hangzhou Youngpeptide Biotechnology HYB

Published 3 Jul 2026. 29-page investigative report on who is behind Hangzhou Youngpeptide Biotechnology HYB: corporate records, ownership, affiliate networks, and the vendor's lab-testing record. The first 4 pages are free to read on this page.

HYB’s Finnrick record is uneven: 21 tests with 14 pass and 7 fail for a 67% overall pass rate, led by GHK-Cu while Retatrutide and Tirzepatide remain mixed. The report examines the R10…